CAPTRUST Financial Advisors’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,889
Closed -$33.1K 2756
2025
Q3
$33.1K Sell
14,889
-2,150
-13% -$5.16K ﹤0.01% 2587
2025
Q2
$24.4K Buy
17,039
+637
+4% +$926 ﹤0.01% 2466
2025
Q1
$26.2K Buy
16,402
+2,073
+14% +$6.18K ﹤0.01% 2310
2024
Q4
$51.6K Sell
14,329
-678
-5% -$3.37K ﹤0.01% 2235
2024
Q3
$85.5K Buy
15,007
+185
+1% +$1.11K ﹤0.01% 2207
2024
Q2
$68.5K Hold
14,822
﹤0.01% 2133
2024
Q1
$121K Hold
14,822
﹤0.01% 2047
2023
Q4
$83.7K Sell
14,822
-33
-0.2% -$75 ﹤0.01% 2545
2023
Q3
$27.6K Sell
14,855
-1,875
-11% -$5.72K ﹤0.01% 2512
2023
Q2
$46K Buy
16,730
+1,388
+9% +$4.46K ﹤0.01% 2434
2023
Q1
$48.2K Buy
+15,342
New +$90.3K ﹤0.01% 2216
2022
Q4
Sell
-14,822
Closed -$130K 2079
2022
Q3
$130K Hold
14,822
﹤0.01% 1901
2022
Q2
$112K Hold
14,822
﹤0.01% 2120
2022
Q1
$360K Sell
14,822
-4,940
-25% -$120K ﹤0.01% 1330
2021
Q4
$636K Sell
19,762
-6,587
-25% -$260K ﹤0.01% 1004
2021
Q3
$1.18M Hold
26,349
0.01% 690
2021
Q2
$997K Buy
26,349
+26,241
+24,297% +$940K 0.01% 720
2021
Q1
$4K Buy
+108
New +$4.3K ﹤0.01% 3797

Other funds holding CCCC